Delivery Order SPE2DB24D2205-SPE2DB25FEGVT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) on August 19, 2025, with completion targeted for September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $21,282.14 delivery order to AmerisourceBergen Drug Corp for TAGRISSO 40 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, firm fixed-price contract represents a delivery order under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) on September 3, 2025, with completion scheduled for September 24, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of TAGRISSO 40 mg tablets (30-count packages) valued at $31,923.21. This firm fixed-price delivery order, issued on August 27, 2025, with completion scheduled for September 18, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at...
- The Defense Logistics Agency awarded a $31,892.74 delivery order to AmerisourceBergen Drug Corp for TAGRISSO (80 mg tablets, 30-count package) under a firm fixed-price contract type. The award was issued on September 17, 2025, with an ultimate completion date of October 8, 2025, and represents a competitively awarded non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, leveraging its established...
- The Defense Logistics Agency awarded a $21,282.14 delivery order to AmerisourceBergen Drug Corp for the supply of TAGRISSO 40 mg tablets (30-count units) under a firm fixed-price contract. The award was made on September 19, 2025, with an ultimate completion date of October 10, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award, reflecting the contractor's capability to...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 20, 2025, for the supply of TAGRISSO 80 mg tablets (30-count units) with a contract value of $10,662.57. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 11, 2025, and performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,871.50 firm fixed-price contract is for the delivery of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,325.14 to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 mg tablets (30-count units) under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by July 14, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TAGRISSO 80 MG TABLET 30S. The contract has a potential value of $21,077.60 and a completion date of March 7, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running through December 31,...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGVTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of TAGRISSO 40 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $10,641.07 and an ultimate completion date of September 17, 2025. The contract utilizes no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is registered in the System for Award Management (SAM.gov). This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime contract vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company's extensive portfolio under this IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 8/26/25 |